Showing results (21-30 of 131) with videos related to
Sort By:
Pageof 14
Health Affairs (Project Hope)|May 6, 2009
Financial penalties for the unhealthy? Ethical guidelines for holding employees responsible for their healthSteven D Pearson, Sarah R LieberValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding DecisionsMark Sculpher, Karl Claxton, Steven D PearsonJournal of Comparative Effectiveness Research|September 19, 2023
White bagging, brown bagging and site of service policies: best practices in addressing provider markup in the commercial insurance marketCaroline Pearson, Lindsey Schapiro, Steven D PearsonJournal of Comparative Effectiveness Research|August 24, 2021
Potential policy reforms to strengthen the accelerated approval pathwayAnna Kaltenboeck, Amanda Mehlman, Steven D PearsonJAMA Internal Medicine|May 8, 2013
Cost consideration in the clinical guidance documents of physician specialty societies in the United StatesJennifer A T Schwartz, Steven D PearsonHealth Affairs (Project Hope)|April 8, 2011
Measuring the performance of individual physicians by collecting data from multiple health plans: the results of a two-state testAparna Higgins, Timothy Zeddies, Steven D PearsonJournal of Comparative Effectiveness Research|August 10, 2022
The next generation of rare disease drug policy: ensuring both innovation and affordabilityCaroline Pearson, Lindsey Schapiro, Steven D PearsonJournal of General Internal Medicine|November 11, 2010
The diagnostic performance of multi-slice coronary computed tomographic angiography: a systematic reviewDaniel A Ollendorf, Michelle Kuba, Steven D PearsonValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?Logan Trenaman, Steven D Pearson, Jeffrey S HochValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 25, 2022
The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of BiologicsStephen J Kogut, Jon D Campbell, Steven D PearsonPageof 14